All In MedTech

FDA Clearance Tracker · P040042-S053

Safire TX Ablation Catheter, Therapy Dual-8 Ablation Catheter, Safire TX, Catheter Extension Cable

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 16, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 16, 2022

Approved

Time to decision

49 days

Received Oct 28, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P040042-S053
Device name
Safire TX Ablation Catheter, Therapy Dual-8 Ablation Catheter, Safire TX, Catheter Extension Cable
Applicant location
Irvine, CA
Received
Oct 28, 2022
Decided
Dec 16, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P040042

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

Approval for Sterigenics Utah as an alternate EO sterilization vendor for Irvine EP cables.

Source documents

Other decisions for Irvine Biomedical,Inc.(Ibi)

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.